| Literature DB >> 35873571 |
Yu-Hao Ni1, Hui-Fang Deng1, Lei Zhou2, Cong-Shu Huang3, Ning-Ning Wang3, Lan-Xin Yue1, Gao-Fu Li1, Hui-Jing Yu4, Wei Zhou1, Yue Gao1.
Abstract
The nephrotoxicity of Fructus Psoraleae, an effective traditional Chinese medicine for vitiligo treatment, has been reported. As one of the main toxic components in Fructus Psoraleae, bavachin (BV) was considered to be related to Fructus Psoraleae-caused adverse outcomes, but the direct evidence and molecular mechanism underlying BV-induced nephrotoxicity are not well elucidated. Therefore, this study was designed to confirm whether BV would cause toxic effects on the kidney and explore the possible mode of action. Our results demonstrated that days' treatment with 0.5 μM BV indeed caused obvious renal fibrosis in the zebrafish kidney. The obvious E- to N-cadherin switch and the expressions of proteins promoting epithelial-mesenchymal transition (EMT) were observed in BV-treated human renal tubular epithelial and zebrafish kidneys. In addition, elevated reactive oxygen species (ROS) levels and Bip/eIF2α/CHOP-mediated endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) were caused by BV, both of which could be reversed by ROS scavenger N-acetyl-L-cysteine (NAC). Also, blocking ER stress-caused cytoplasmic Ca2+ overload with 4-PBA notably alleviated BV-induced alterations in key molecular events related to EMT and renal fibrosis. Furthermore, of the natural compounds subjected to screening, ginsenoside Rb1 significantly downregulated BV-induced ER stress by inhibiting ROS generation and following the activation of Bip/eIF2α/CHOP signaling in HK2 cells. Subsequently, BV-triggered EMT and renal fibrosis were both ameliorated by ginsenoside Rb1. In summary, our findings suggested that BV-induced ROS promoted the appearance of EMT and renal fibrosis mainly via Bip/eIF2α/CHOP-mediated ER stress. This ER stress-related toxic pathway might be a potential intervention target for BV-caused renal fibrosis, and ginsenoside Rb1 would be a promising drug against BV- or Fructus Psoraleae-induced nephrotoxicity.Entities:
Keywords: EMT; ER stress; bavachin; ginsenoside Rb1; renal fibrosis
Year: 2022 PMID: 35873571 PMCID: PMC9304982 DOI: 10.3389/fphar.2022.872474
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
Information for all indicated antibodies used in western blots assay.
| Name | Company | Dilution rate | |
|---|---|---|---|
| 1 | α-SMA | 19,245, Cell Signaling Technology, United States | 1:1,000 |
| 2 | Notch1 | 3,608, Cell Signaling Technology, United States | 1:1,000 |
| 3 | c-Myc | 18,583, Cell Signaling Technology, United States | 1:1,000 |
| 4 | Hes1 | 11,988, Cell Signaling Technology, United States | 1:1,000 |
| 5 | NICD | 4,147, Cell Signaling Technology, United States | 1:1,000 |
| 6 | GAPDH | 200,310-4F11, ZEN BIO, China | 1:1,000 |
| 7 | E-Cadherin | 66009-1-Ig, Proteintech, United States | 1:1,000 |
| 8 | N-Cadherin | 13,116, Cell Signaling Technology, United States | 1:1,000 |
| 9 | Vimentin | 5,741, Cell Signaling Technology, United States | 1:1,000 |
| 10 | ATP1A1 | ab7671, Cell Signaling Technology, United States | 1:1,000 |
| 11 | AQP1 | ab168387, Abcam, United States | 1:1,000 |
| 12 | SLC22A6 | ab135924, Abcam, United States | 1:1,000 |
| 13 | ZEB1 | 70,512, Cell Signaling Technology, United States | 1:1,000 |
| 14 | Claudin-1 | 13,995, Cell Signaling Technology, United States | 1:1,000 |
| 15 | Slug | 9,585, Cell Signaling Technology, United States | 1:1,000 |
| 16 | ZO-1 | 13,663, Cell Signaling Technology, United States | 1:1,000 |
| 17 | Bip | 3,177, Cell Signaling Technology, United States | 1:1,000 |
| 18 | ATF6 | 500,202, ZEN BIO, China | 1:1,000 |
| 19 | p-perk | 340,846, ZEN BIO, China | 1:1,000 |
| 20 | ATF-4 | 11,815, Cell Signaling Technology, United States | 1:1,000 |
| 21 | IRE1α | 3,294, Cell Signaling Technology, United States | 1:1,000 |
| 22 | XBP-1s | 12,782, Cell Signaling Technology, United States | 1:1,000 |
| 23 | CHOP | 15204-1-AP, Proteintech, United States | 1:1,000 |
| 24 | Anti-Rb IgG | ab6721, Abcam, United States | 1:3,000 |
| 25 | Anti-Ms IgG | ab6789, Abcam, United States | 1:3,000 |
| 26 | p-eIF2α | 310,073, ZEN BIO, China | 1:1,000 |
| 28 | Smad3 | 385,743, ZEN BIO, China | 1:1,000 |
FIGURE 1Long-term treatment with a low dose of BV-induced renal fibrosis in zebrafish. (A) Chemical structure of BV. (B) LC50 of BV on zebrafish after 4 days of treatment was calculated. (C) Body weight and condition factor of zebrafish after 21 days BV treatment (n = 30). (D) Masson trichrome staining of zebrafish kidney treated with solvent or BV, respectively. (E) The contents of N-cadherin and AQP1 in zebrafish kidneys were detected by in situ hybridization. ns means no significant difference. **p < 0.01, ***p < 0.001, and ****p < 0.0001 vs. the control groups.
FIGURE 2BV caused perturbations in ER stress-, fibrosis- and EMT-relevant signaling pathways in vitro. (A) Cell viability of HK2 cells after 24 h BV treatment was detected by CCK-8 assay. The expressions of indicated proteins involved in fibrosis (B) and EMT (C) in HK2 cells were measured using western blot. (D) The expressions of ER stress and UPR-associated proteins in BV-treated cells. (E) The intracellular concentration of Ca2+ was demonstrated using Fluo 4-AM (scale bar: 100 μm). *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the control groups.
FIGURE 3Elevating ROS contributed to BV-triggered ER stress and EMT. (A) Intracellular ROS levels in HK2 cells induced by BV with or without NAC treatment (scale bar: 100 μm). After NAC treatment, ER stress- (B), EMT- (D) related proteins, and cellular Ca2+ concentration (C) were detected with western blot and Fluo 4-AM, respectively. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the control groups. p < 0.05, p < 0.01, and p < 0.001 vs. the BV-treated groups.
FIGURE 4Inhibition of ROS-mediated ER stress reversed BV-triggered EMT and profibrotic signaling. After 24 h BV treatment with/without 4-PBA co-treatment, the expressions of ER stress (A), EMT (B), and fibrosis-related (C) proteins were examined by western blot. (D–F)The expressions of indicated proteins in TM-treated HK2 cells. (G) BV-induced profibrotic signaling in NAC cotreated HK2 cells was detected. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the control groups. p < 0.05, p < 0.01, and p < 0.001 vs. the BV-treated groups.
FIGURE 5Ginsenoside Rb1 alleviated BV-induced EMT and renal fibrosis by downregulating ROS-mediated ER stress. (A) Screening for the drug inhibiting intracellular Ca2+ release. (B) After ginsenoside Rb1 cotreatment, the ROS levels in each group were detected (scale bar: 100 μm). The indicated proteins participating in ER stress (C), EMT (D), and fibrosis (E) in HK2 cells cotreated BV with/without ginsenoside Rb1. (F) Masson trichrome staining of zebrafish kidney cotreated BV with/without ginsenoside Rb1. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the control groups. p < 0.05, p < 0.01, and p < 0.001 vs. the BV-treated groups.
FIGURE 6Schematic representation of the potential molecular mechanism underlying BV-induced renal fibrosis.